Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilance.
Key Points
To analyze and describe the characteristics of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) as a severe adverse drug reaction.
Detailed analysis of pharmacovigilance data related to DRESS cases.
Assessment of morbidity and mortality associated with DRESS.
Identification of early signs for better recognition.
DRESS is associated with high morbidity and mortality rates.
Early recognition is crucial for patient outcomes.
Continuous pharmacovigilance is necessary to mitigate risks.
Abstract
DRESS remains a severe adverse drug reaction. Early recognition and continuous pharmacovigilance are essential to reduce associated morbidity and mortality.
Like
Bookmark
Share
Like
Bookmark
Share
Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilance. | Synapse